16.35NOK+0.31%Mkt Cap: 36.65M $P/E: —1d ago
Navamedic ASA, a pharmaceutical company, develops, produces, markets, and sells pharmaceuticals and related products in Norway, Sweden, Denmark, Finland, the Netherlands, and internationally. Its product portfolio includ…
Indicators:|
Key Statistics
Company
Market Cap36.65M $
Enterprise Value48.63M $
Revenue (TTM)53.40M $
Gross Profit20.60M $
Net Income (TTM)-2.20M $
Revenue/Share2.607 USD
Last Price16.35 NOK
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees38
CountryNO
SectorHealthcare
IndustryMedical Distribution
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)24.40
PEG1.38
EV/EBITDA11.76
EV/Revenue0.91
P/S0.69
P/B1.22
EPS (TTM)-1.24
EPS (Forward)0.67
52W Range
15.705% of range27.90
52W High27.90 NOK
52W Low15.70 NOK
Profitability
Gross Margin38.97%
Oper. Margin1.32%
EBITDA Margin7.75%
Profit Margin-4.16%
ROE-7.05%
ROA-3.17%
Growth
Revenue Growth4.50%
Earnings Growth—
Cash Flow & Leverage
Operating CF2.39M $
CapEx (TTM)222.57K $
FCF Margin4.07%
FCF Yield5.93%
Net Debt12.87M $
Net Debt/EBITDA3.11
Balance Sheet
Debt/Equity0.68
Current Ratio1.47
Quick Ratio0.76
Book Value/Sh13.37 NOK
Cash/Share2.868 NOK
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 NOK
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div DateApr 13, 2010
Pay Date—
Analyst Consensus
Rating—
Target (Mean)26.00 NOK
Upside (mean)+59.0%
Target Range26.00 NOK – 26.00 NOK
# Analysts1
Ownership
Shares Out.23.98M
Float14.97M
Insiders28.28%
Institutions39.61%
Technical
SMA 5018.06 (-9.5%)
SMA 20020.80 (-21.4%)
Beta0.22
S&P 52W Chg20.05%
Avg Vol (30d)237.49K
Avg Vol (10d)14.47K
Technical Indicators
RSI (14)33.5
MACD-0.4988
MACD Signal-0.5246
MACD Hist.+0.0258
BB Upper17.46 NOK
BB Middle16.75 NOK
BB Lower16.05 NOK
BB Width8.45%
ATR (14)0.4715 NOK
Vol Ratio (20d)1.75x